Search - tctmd.com

Displaying 201 - 220 of 670

Sort: Relevancy | Date

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

L.A. McKeown

June 01, 2022

News Conference News EuroPCR 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Michael O'Riordan

May 23, 2022

News Conference News SCAI 2022

Low Household Income Predicts Risk of Death During STEMI Hospitalization

L.A. McKeown

May 19, 2022

News Conference News EuroPCR 2022

Registry Data Hint at MACE Benefit With Renal Denervation

Michael O'Riordan

May 17, 2022

News Daily News

Worse Survival for Women After Ruptured AAA Repair

L.A. McKeown

May 11, 2022

News Daily News

Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions

L.A. McKeown

May 06, 2022

News Daily News

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

L.A. McKeown

May 05, 2022

News Daily News

NCDR Analyses Offer Insights Into First-Generation Watchman Outcomes

L.A. McKeown

May 03, 2022

News Daily News

COVID-19: TCTMD’s Dispatch for May Week 1

Todd Neale

May 02, 2022

News Opinion CV Team Dispatch

May 2022 News Roundup

L.A. McKeown

May 01, 2022

News Daily News

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Michael O'Riordan

April 29, 2022

News Daily News

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

Michael O'Riordan

April 27, 2022

News Daily News

SCAI-Led Position Statement on CLTI Spotlights Multispeciality Involvement

L.A. McKeown

April 27, 2022

News Daily News

Medtronic Recalls Harmony Delivery Catheters Due to Breakage Risk

L.A. McKeown

April 26, 2022

News Daily News

Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities

Michael O'Riordan

April 25, 2022

News Conference News ACC 2022

SPYRAL HTN-ON MED at 3 Years: Renal Denervation’s BP Impact Endures

Todd Neale

April 08, 2022

News Conference News ACC 2022

QoL Gains Within 15 Days in Acute HF With Empagliflozin: EMPULSE Analysis

L.A. McKeown

April 07, 2022

News Conference News ACC 2022

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

Michael O'Riordan

April 06, 2022

News Conference News ACC 2022

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Todd Neale

April 05, 2022

News Conference News ACC 2022

Better Angina Relief With Complete PCI in STEMI and MVD

L.A. McKeown

April 02, 2022

Advertisement

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Low Household Income Predicts Risk of Death During STEMI Hospitalization

Registry Data Hint at MACE Benefit With Renal Denervation

Worse Survival for Women After Ruptured AAA Repair

Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

NCDR Analyses Offer Insights Into First-Generation Watchman Outcomes

COVID-19: TCTMD’s Dispatch for May Week 1

May 2022 News Roundup

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

SCAI-Led Position Statement on CLTI Spotlights Multispeciality Involvement

Medtronic Recalls Harmony Delivery Catheters Due to Breakage Risk

Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities

SPYRAL HTN-ON MED at 3 Years: Renal Denervation’s BP Impact Endures

QoL Gains Within 15 Days in Acute HF With Empagliflozin: EMPULSE Analysis

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Better Angina Relief With Complete PCI in STEMI and MVD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content